SCN8A and epilepsy: We aim to describe the stereo-EEG (SEEG) evaluation results and resective surgery outcome in a patient with epilepsy related to SCN8A mutation (c.2671G > A, p.Val891Met, heterozygous) which was initially reported as a variant of uncertain significance (VUS) at time of his pre-surgical evaluation, but later reclassified as likely pathogenic 3 years after his SEEG monitoring (2 years 10 months after resective epilepsy surgery).